A retrospective study of the pregnancy, delivery and neonatal outcome in overweight versus normal weight women with polycystic ovary syndrome.

STUDY QUESTION Do overweight women with polycystic ovary syndrome (PCOS) have a higher risk of perinatal complications than normal weight women with PCOS? SUMMARY ANSWER Overweight women with PCOS with an ongoing singleton pregnancy have an increased risk of preterm birth as well as an increased risk of giving birth to a baby with a higher birthweight than normal weight women with PCOS. WHAT IS KNOWN ALREADY There is evidence that overweight (BMI > 25 kg/m²) has a negative influence on the prevalence of gestational diabetes mellitus and fetal macrosomia in women with PCOS. STUDY DESIGN, SIZE, DURATION We set up a retrospective comparative cohort study of 93 overweight (BMI ≥ 25 kg/m²) and 107 normal weight (BMI < 25 kg/m²) women with PCOS who were scheduled for fertility treatment between January 2000 and December 2009 and achieved a pregnancy as a result of a treatment cycle, or spontaneously before or between treatment cycles. PARTICIPANTS/MATERIALS, SETTING, METHODS All data (patient characteristics, medical information, pregnancy, delivery and neonatal outcome) were retrieved from patient medical files. All pregnancy, delivery and neonatal outcome parameters were adjusted for age and pre-pregnancy smoking behaviour. The neonatal outcome parameters were additionally adjusted for gestational age. MAIN RESULTS AND THE ROLE OF CHANCE The median BMI in the overweight and normal weight women was, respectively, 30.8 kg/m² [interquartile quartile range (IQR) 5.8] and 20.9 kg/m² (IQR 2.3) (P < 0.001). Baseline characteristics did not differ between groups, except for free testosterone and fasting insulin levels, which were higher, and sex hormone-binding globulin, which was lower, in overweight versus normal weight women (all P < 0.001). The time-to-pregnancy was significantly higher in the overweight group (P = 0.01). Multivariate analyses of the ongoing singleton pregnancies showed significantly more preterm births in overweight (10/61) versus normal weight (2/71) women [adjusted odds ratio 0.1, 95% confidence interval (CI) 0-0.6, P = 0.01]. The mean birthweight of newborns was significantly higher in overweight (3386 ± 663 g) than in normal weight (3251 ± 528 g) women (adjusted mean difference 259.4, 95% CI 83.4-435.4, P = 0.004). LIMITATIONS, REASON FOR CAUTION Our results only represent the pregnancy, delivery and neonatal outcome of ongoing singleton pregnancies. The rather small sample size and observational nature of the study are further limitations. WIDER IMPLICATIONS OF THE FINDINGS Our results suggest the importance of pre-pregnancy weight loss in overweight women with PCOS in order to reduce the risk of adverse perinatal outcomes. STUDY FUNDING/COMPETING INTERESTS Veerle De Frène is holder of a Special PhD Fellowship by the Flemish Foundation for Scientific Research (FWO-Vlaanderen). Petra De Sutter is holder of a fundamental clinical research mandate by the Flemish Foundation for Scientific Research (FWO-Vlaanderen). There are no competing interests.

[1]  Robert R. Henry,et al.  Type 2 diabetes mellitus , 2015, Nature Reviews Disease Primers.

[2]  B. de Courten,et al.  Obesity and polycystic ovary syndrome. , 2015, Minerva endocrinologica.

[3]  A. Kriplani,et al.  Polycystic ovary syndrome: Novel insights into causes and therapy , 2014 .

[4]  J. Crane,et al.  Maternal and perinatal outcomes of extreme obesity in pregnancy. , 2013, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[5]  M. Blomberg Maternal Obesity, Mode of Delivery, and Neonatal Outcome , 2013, Obstetrics and gynecology.

[6]  Mu-Jun Li,et al.  Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis , 2013, Reproductive Biology and Endocrinology.

[7]  S. Cnattingius,et al.  Maternal Obesity and Risk of Preterm Delivery , 2014 .

[8]  F. Ghaffarpasand,et al.  Correlation between thrombophilia and recurrent pregnancy loss in patients with polycystic ovary syndrome: A comparative study , 2013, Journal of the Chinese Medical Association : JCMA.

[9]  E. Nuyts,et al.  Socio‐demographic and obstetrical correlates of pre‐pregnancy body mass index and gestational weight gain , 2012, Clinical obesity.

[10]  R. Norman,et al.  Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. , 2012, The Cochrane database of systematic reviews.

[11]  Andrew L. DaLio The impact of obesity , 2011 .

[12]  M. Koong,et al.  Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control study , 2011, Clinical and experimental reproductive medicine.

[13]  L. Sanchez-Ramos,et al.  Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis. , 2011, American journal of obstetrics and gynecology.

[14]  R. Pasquali,et al.  Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes. , 2010, European journal of obstetrics, gynecology, and reproductive biology.

[15]  J. Vrbíková,et al.  Obesity and Polycystic Ovary Syndrome , 2009, Obesity Facts.

[16]  S. Goetgeluk,et al.  Pregnancy outcome in primiparae of advanced maternal age. , 2007, European journal of obstetrics, gynecology, and reproductive biology.

[17]  A. Perciaccante,et al.  Polycystic ovary syndrome: androgens, autonomic nervous system, and hypertension. , 2007, Hypertension.

[18]  M. Eijkemans,et al.  A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. , 2006, Human reproduction update.

[19]  M. Eijkemans,et al.  PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO‐II anovulation and association with metabolic factors , 2006, BJOG : an international journal of obstetrics and gynaecology.

[20]  J. Land How should we report on perinatal outcome? , 2006, Human reproduction.

[21]  U. Pagotto,et al.  Review article: The impact of obesity on reproduction in women with polycystic ovary syndrome , 2006 .

[22]  A. Perciaccante,et al.  Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus , 2006, BMC cardiovascular disorders.

[23]  Edoardo Cervoni Impact of obesity. , 2005, The British journal of general practice : the journal of the Royal College of General Practitioners.

[24]  T. Buchanan,et al.  Gestational diabetes mellitus. , 2005, The Journal of clinical investigation.

[25]  D. Guzick,et al.  A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. , 2004, Fertility and sterility.

[26]  N. Turhan,et al.  Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[27]  R. Norman,et al.  Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. , 2001, Human reproduction.

[28]  P. Claman,et al.  Obstetric outcome in women with polycystic ovarian syndrome. , 2001, Human reproduction.

[29]  V. Hiilesmaa,et al.  Obstetric outcome in women with polycystic ovarian syndrome. , 2001, Human reproduction.

[30]  R. Storeng,et al.  Obesity is a risk factor for early pregnancy loss after IVF or ICSI , 2000, Acta obstetricia et gynecologica Scandinavica.

[31]  E. Lunenfeld,et al.  Obstetric outcome of singleton pregnancies conceived by in vitro fertilization and ovulation induction compared with those conceived spontaneously. , 1998, Fertility and sterility.

[32]  T. Li,et al.  Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function. , 1998, Fertility and sterility.

[33]  K. Balanda,et al.  Evaluation of antenatal smoking cessation programs for pregnant women , 1998, Australian and New Zealand journal of public health.

[34]  J. Van der Elst,et al.  Perinatal Outcome of Pregnancies After Assisted Reproduction: A Case–Control Study , 1997, Journal of Assisted Reproduction and Genetics.

[35]  P. Vollenweider,et al.  Body fat and sympathetic nerve activity in healthy subjects. , 1994, Circulation.

[36]  R. Troisi,et al.  Relation of Obesity and Diet to Sympathetic Nervous System Activity , 1991, Hypertension.

[37]  L. Regan,et al.  Hypersecretion of luteinising hormone, infertility, and miscarriage , 1990, The Lancet.

[38]  P. Rosenbaum The Consequences of Adjustment for a Concomitant Variable that Has Been Affected by the Treatment , 1984 .

[39]  Z. Anusz [Statistics in epidemiology]. , 1974, Pielegniarka i polozna.

[40]  M. Pfeifer,et al.  Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome. , 2013, Frontiers of hormone research.

[41]  U. Pagotto,et al.  The impact of obesity on reproduction in women with polycystic ovary syndrome. , 2006, BJOG : an international journal of obstetrics and gynaecology.

[42]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[43]  Luca Gianaroli,et al.  Multiple gestation pregnancy , 2000 .